MESENCHYMAL STEM CELLS AND FIBROBLASTS IN AGE-RELATED REMODELING OF THE MUSCULOSKELETAL SYSTEM
- 30 September 2024
- journal article
- Published by Technomed Holdings LLC in Bulletin "Biomedicine and sociology"
Abstract
Mesenchymal stem/stromal cells (MSCs) and fibroblasts are present in normal tissues to maintain tissue homeostasis and share a number of common features such as spindle-shaped morphology, localization in connective tissue, and multipotency. During inflammation, fibroblasts and MSCs non-specifically respond to injury via two mechanisms of action: immunomodulation and regeneration. Upon tissue injury, MSCs are activated, proliferate, and differentiate. With age and, in particular, in degenerative diseases of the musculoskeletal system (diseases of the muscles, joints and bones), the regenerative capacity of MSCs is lost or redirected to the production of other non-functional cell types such as adipocytes and fibroblasts, which provide much of the structural framework of almost all tissue types. By performing an immunosuppressive role, MSCs and fibroblasts contribute to the normal resolution of inflammation, which is a prerequisite for successful tissue repair. The aim of the review is to provide an understanding of the common and opposite properties of MSCs and FB from the standpoint of age-related changes in the musculoskeletal system in order to develop approaches to their complementary assistance for successful tissue regeneration. The key features of aging MSC and fibroblast are presented, and it is indicated that additional studies are needed on the cellular mechanisms that together generate dysfunctions of individual niches of terminal differentiated cells during aging. The currently existing technologies of cell therapy for the musculoskeletal system diseases involving MSCs and fibroblasts are presented.Keywords
This publication has 35 references indexed in Scilit:
- The plasticity of fibroblasts: A forgotten player in the aging processAgeing Research Reviews, 2023
- Age-related alterations and senescence of mesenchymal stromal cells: Implications for regenerative treatments of bones and jointsMechanisms of Ageing and Development, 2021
- Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclatureCytotherapy, 2019
- Small Extracellular Vesicles Are Key Regulators of Non-cell Autonomous Intercellular Communication in Senescence via the Interferon Protein IFITM3Cell Reports, 2019
- Human umbilical cord blood mesenchymal stem cells expansion via human fibroblast-derived matrix and their potentials toward regenerative applicationCell and tissue research, 2019
- Age-related changes in skeletal muscle: changes to life-style as a therapyBiogerontology, 2018
- Identification of the Human Skeletal Stem CellCell, 2018
- Leptin-Receptor-Expressing Mesenchymal Stromal Cells Represent the Main Source of Bone Formed by Adult Bone MarrowCell Stem Cell, 2014
- Matrix-directed differentiation of human adipose-derived mesenchymal stem cells to dermal-like fibroblasts that produce extracellular matrixJournal of Tissue Engineering and Regenerative Medicine, 2014
- The depletion of skeletal muscle satellite cells with age is concomitant with reduced capacity of single progenitors to produce reserve progenyDevelopmental Biology, 2010